A detailed history of Smartleaf Asset Management LLC transactions in Genmab A/S stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 2,323 shares of GMAB stock, worth $53,684. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,323
Previous 2,200 5.59%
Holding current value
$53,684
Previous $70.3 Million 15.44%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.13 - $30.27 $3,090 - $3,723
123 Added 5.59%
2,323 $59.4 Million
Q1 2024

Oct 07, 2024

SELL
$26.43 - $32.77 $3,250 - $4,030
-123 Reduced 5.29%
2,200 $67.4 Million
Q1 2024

May 02, 2024

BUY
$26.43 - $32.77 $1,453 - $1,802
55 Added 2.56%
2,200 $70.3 Million
Q4 2023

Feb 12, 2024

BUY
$27.94 - $35.44 $59,931 - $76,018
2,145 New
2,145 $68.5 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $15.2B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.